Synthetic Bone Grafting in Foot and Ankle Surgery

Foot and Ankle Clinics

Volumn 15, Issue 4, 2010, Pages 559-576

  Panchbhavi, Vinod K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Calcium phosphate; Calcium sulfate; Synthetic bone graft

Indexed keywords

ANTIINFECTIVE AGENT; BONE CEMENT; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CALCIUM SULFATE; POLY(METHYL METHACRYLATE); TISSUE SCAFFOLD;

ANIMAL; ANKLE; ANKLE INJURY; BONE PROSTHESIS; BONE REGENERATION; FOOT; FOOT INJURY; FRACTURE; HUMAN; METHODOLOGY; ORTHOPEDIC SURGERY; REVIEW;

ANIMALS; ANKLE; ANKLE INJURIES; ANTI-BACTERIAL AGENTS; BONE CEMENTS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CALCIUM SULFATE; FOOT; FOOT INJURIES; FRACTURES, BONE; HUMANS; ORTHOPEDIC PROCEDURES; POLYMETHYL METHACRYLATE; TISSUE SCAFFOLDS;

EID: 78149364464     PISSN: 10837515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fcl.2010.07.004     Document Type: Review

References (89)

1. Fleming J.E., Cornell C.N., Muschler G.F. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am 2000, 31:357-374.
2. Stevenson S. Biology of bone grafts. Orthop Clin North Am 1999, 30:543-552.
3. Banwart J.C., Asher M.A., Hassanein R.S. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995, 20:1055-1060.
4. Hill N.M., Horne J.G., Devane P.A. Donor site morbidity in the iliac crest bone graft. Aust N Z J Surg 1999, 69:726-728.
5. Schnee C.L., Freese A., Weil R.J., et al. Analysis of harvest morbidity and radiographic outcome using autograft for anterior cervical fusion. Spine 1997, 22:2222-2227.
6. Younger E.M., Chapman M.W. Morbidity at bone graft donor sites. J Orthop Trauma 1989, 3:192-195.
7. Boyce T., Edwards J., Scarborough N. Allograft bone. The influence of processing on safety and performance. Orthop Clin North Am 1999, 30:571-581.
8. Screening and testing of donors of human tissue intended for transplantation 1977, FDA, Center for Biologics Evaluation and Research, Washington, DC.
9. Kagan R.J. Standards for tissue banking 1998, American Association of Tissue Banks, McLean (VA).
10. Buck B.E., Malinin T.I., Brown M.D. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res 1989, 240:129-136.
11. Delloye C., Hebrant A., Munting E., et al. The osteoinductive capacity of differently HCl-decalcified bone alloimplants. Acta Orthop Scand 1985, 56:318-322.
12. Cornell C.N., Lane J.M. Current understanding of osteoconduction in bone regeneration. Clin Orthop Relat Res 1998, 355(Suppl):S267-S273.
13. Kühne J.H., Bartl R., Frisch B., et al. Bone formation in coralline hydroxyapatite. Effects of pore size studied in rabbits. Acta Orthop Scand 1994, 65:246-252.
14. Nakahara H., Goldberg V.M., Caplan A.I. Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium phosphate ceramics in vivo. Clin Orthop Relat Res 1992, 276:291-298.
15. Peltier L.F., Jones R.H. Treatment of unicameral bone cysts by curettage and packing with plaster-of-Paris pellets. J Bone Joint Surg Am 1978, 60:820-822.
16. Yamamuro T. Bone bonding behavior and clinical use of A-W glass-ceramic. Bone grafts, derivatives and substitutes 1994, 245-259. Butterworth-Heinemann, Oxford (UK). M.R. Urist, B.T. O'Connor, R.G. Burwell (Eds.).
17. Carson J.S., Bostrom M.P. Synthetic bone scaffolds and fracture repair. Injury 2007, 38(Suppl 1):S33-S37.
18. Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Injury 2000, 31(Suppl 4):37-47.
19. Bauer T.W., Smith S.T. Bioactive materials in orthopaedic surgery: overview and regulatory considerations. Clin Orthop Relat Res 2002, 395:11-22.
20. Bhattacharyya T., Tornetta P., Healy W.L., et al. The validity of claims made in orthopaedic print advertisements. J Bone Joint Surg Am 2003, 85:1224-1228.
21. Dreesmann H. Uber Knochenplombierung. Bietr Klin Chir 1892, 9:804-810.
22. Peltier L.F. The use of plaster of Paris to fill large defects in bone. Am J Surg 1959, 97:311-315.
23. Peltier L.F. The use of plaster of Paris to fill defects in bone. Clin Orthop Relat Res 1961, 21:1-31.
24. Gazdag A.R., Lane J.M., Glaser D., et al. Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg 1995, 3:1-8.
25. Mirzayan R., Panossian V., Avedian R., et al. The use of calcium sulfate in the treatment of benign bone lesions. A preliminary report. J Bone Joint Surg Am 2001, 83:355-358.
26. Walsh W.R., Morberg P., Yu Y., et al. Response of a calcium sulfate bone graft substitute in a confined cancellous defect. Clin Orthop Relat Res 2003, 406:228-236.
27. Sidqui M., Collin P., Vitte C., et al. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biomaterials 1995, 16:1327-1332.
28. Bucholz R.W. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 2002, 395:44-52.
29. Turner T.M., Urban R.M., Gitelis S., et al. Radiographic and histologic assessment of calcium sulfate in experimental animal models and clinical use as a resorbable bone-graft substitute, a bone-graft expander, and a method for local antibiotic delivery: one institution's experience. J Bone Joint Surg Am 2001, 83(Suppl 2[Pt 1]):8-18.
30. Urban R.M., Turner T.M., Hall D.J., et al. Healing of large defects treated with calcium sulfate pellets containing demineralized bone matrix particles. Orthopedics 2003, 26(Suppl 5):s581-s585.
31. Turner T.M., Urban R.M., Gitelis S., et al. Resorption evaluation of a large bolus of calcium sulfate in a canine medullary defect. Orthopedics 2003, 26(Suppl 5):s577-s579.
32. Kelly C.M., Wilkins R.W., Gitelis S., et al. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop Relat Res 2001, 382:42-50.
33. Hak D.J. The use of osteoconductive bone graft substitutes in orthopaedic trauma. J Am Acad Orthop Surg 2007, 15:525-536.
34. Pietrzak W.S., Ronk R. Calcium sulfate bone void filler: a review and a look ahead. J Craniofac Surg 2000, 11:327-333.
35. Watson J.T. The use of an injectable bone graft substitute in tibial metaphyseal fractures. Orthopedics 2004, 27(Suppl 1):s103-s107.
36. Borelli J., Prickett W.D., Ricci W.M. Treatment of nonunions and osseous defects with bone graft and calcium sulfate. Clin Orthop Relat Res 2003, 411:245-254.
37. Gitelis S., Piasecki P., Turner T., et al. The use of a calcium sulfate-based bone graft substitute for benign bone lesions. Orthopedics 2001, 24:162-166.
38. Panchbhavi V.K. Augmentation of internal fixation of osteoporotic ankle fracture using injectable bone substitute. Tech Foot Ankle Surg 2007, 6:264-269.
39. McKee M.D., Wild L.M., Schemitsch E.H., et al. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results in a prospective trial. J Orthop Trauma 2002, 16:622-627.
40. De Long W.G., Einhorn T.A., Koval K., et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 2007, 89:649-658.
41. Frankenburg E.P., Goldstein S.A., Bauer T.W., et al. Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint Surg Am 1998, 80:1112-1124.
42. Constantz B.R., Ison I.C., Fulmer M.T., et al. Skeletal repair by in situ formation of the mineral phase of bone. Science 1995, 267:1796-1799.
43. Goodman S.B., Bauer T.W., Carter D., et al. Norian SRS cement augmentation in hip fracture treatment: laboratory and initial clinical results. Clin Orthop Relat Res 1998, 348:42-50.
44. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res 1981, 157:259-278.
45. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 2002, 395:81-98.
46. Knaack D., Goad M.E., Aiolova M., et al. Resorbable calcium phosphate bone substitute. J Biomed Mater Res 1998, 43:399-409.
47. Wiltfang J., Merten H.A., Schlegel K.A., et al. Degradation characteristics of α and β tri-calcium-phosphate (TCP) in minipigs. J Biomed Mater Res 2002, 63:115-121.
48. Welkerling H., Raith J., Kastner N., et al. Painful soft-tissue reaction to injectable Norian SRS calcium phosphate cement after curettage of enchondromas. J Bone Joint Surg Br 2003, 85:238-239.
49. Eriksson F., Mattsson P., Larsson S. The effect of augmentation with resorbable or conventional bone cement on the holding strength for femoral neck fracture devices. J Orthop Trauma 2002, 16:302-310.
50. Desai B.M. Osteobiologics. Am J Orthop (Belle Mead NJ) 2007, 36(Suppl 4):8-11.
51. Cassidy C., Jupiter J.B., Cohen M., et al. Norian SRS cement compared with conventional fixation in distal radial fractures. A randomized study. J Bone Joint Surg Am 2003, 85:2127-2137.
52. Hinz P., Wolf E., Schwesinger G., et al. A new resorbable bone void filler in trauma: early clinical experience and histologic evaluation. Orthopedics 2002, 25(Suppl 5):s597-s600.
53. Frayssinet P., Gineste L., Conte P., et al. Short-term implantation effects of a DCPD-based calcium phosphate cement. Biomaterials 1998, 19:971-977.
54. Bajammal S.S., Zlowodzki M., Lelwica A., et al. The use of calcium phosphate bone cement in fracture treatment. A meta-analysis of randomized trials. J Bone Joint Surg Am 2008, 90:1186-1196.
55. Benirschke S.K., Sangeorzan B.J. Extensive intraarticular fractures of the foot. Surgical management of calcaneal fractures. Clin Orthop Relat Res 1993, 292:128-134.
56. Sanders R. Displaced intra-articular fractures of the calcaneus. J Bone Joint Surg Am 2000, 82:225-250.
57. Longino D., Buckley R.E. Bone graft in the operative treatment of displaced intraarticular calcaneal fractures: is it helpful?. J Orthop Trauma 2001, 15:280-286.
58. Kiyoshige Y., Takagi M., Hamasaki M. Bone-cement fixation for calcaneus fracture-a report on 2 elderly patients. Acta Orthop Scand 1997, 68:408-409.
59. Thordarson D.B., Hedman T.P., Yetkinler D.N., et al. Superior compressive strength of a calcaneal fracture construct augmented with remodelable cancellous bone cement. J Bone Joint Surg Am 1999, 81:239-246.
60. Schildhauer T.A., Bauer T.W., Josten C., et al. Open reduction and augmentation of internal fixation with an injectable skeletal cement for the treatment of complex calcaneal fractures. J Orthop Trauma 2000, 14:309-317.
61. Bloemers F.W., Stahl J.P., Sarkar M.R., et al. Bone substitution and augmentation in trauma surgery with a resorbable calcium phosphate bone cement. Eur J Trauma 2004, 30:17-22.
62. Sarkar M.R., Stahl J.P., Wachter N., et al. Defect reconstruction in articular calcaneus fractures with novel calcium phosphate cement. Eur J Trauma 2002, 28:340-348.
63. Csizy M., Buckley R.E., Fennell C. Benign calcaneal bone cyst and pathologic fracture-surgical treatment with injectable calcium-phosphate bone cement (Norian): a case report. Foot Ankle Int 2001, 22:507-510.
64. Larsson S., Bauer T. Use of injectable calcium phosphate cement for fracture fixation: a review. Clin Orthop Relat Res 2002, 395:23-32.
65. Sarkar M.R., Wachter N., Patka P., et al. First histological observations on the incorporation of a novel calcium phosphate bone substitute material in human cancellous bone. J Biomed Mater Res 2001, 58:329-334.
66. Johal H.S., Buckley R.E., Le I.L., et al. A prospective randomized controlled trial of a bioresorbable calcium phosphate paste (α-BSM) in treatment of displaced intraarticular calcaneal fractures. J Trauma 2009, 67:875-882.
67. Moore W.R., Graves S.E., Bain G.I. Synthetic bone graft substitutes. ANZ J Surg 2001, 71:354-361.
68. Cameron H.U. Tricalcium phosphate as a bone graft substitute. Contemp Orthop 1992, 25:506-508.
69. McAndrew M.P., Gorman P.W., Lange T.A. Tricalcium phosphate as a bone graft substitute in trauma: preliminary report. J Orthop Trauma 1988, 2:333-339.
70. Urban R.M., Turner T.M., Hall D.J., et al. Increased bone formation using calcium sulfate-calcium phosphate composite graft. Clin Orthop Relat Res 2007, 459:110-117.
71. Wittenberg R.H., Lee K.S., Shea M., et al. Effect of screw diameter, insertion technique, and bone cement augmentation of pedicular screw fixation strength. Clin Orthop Relat Res 1993, 296:278-287.
72. Zindrick M.R., Wiltse L.L., Widell E.H., et al. A biomechanical study of intrapeduncular screw fixation in the lumbosacral spine. Clin Orthop Relat Res 1986, 203:99-112.
73. Harrington K.D. The use of methylmethacrylate as an adjunct in the internal fixation of unstable comminuted intertrochanteric fractures in osteoporotic patients. J Bone Joint Surg Am 1975, 57:744-750.
74. Bartucci E.J., Gonzalez M.H., Cooperman D.R., et al. The effect of adjunctive methylmethacrylate on failures of fixation and function in patients with intertrochanteric fractures and osteoporosis. J Bone Joint Surg Am 1985, 67:1094-1107.
75. Stürup J., Nimb L., Kramhøft M., et al. Effects of polymerization heat and monomers from acrylic cement on canine bone. Acta Orthop Scand 1994, 65:20-23.
76. Wilkes R.A., Mackinnon J.G., Thomas W.G. Neurological deterioration after cement injection into a vertebral body. J Bone Joint Surg Br 1994, 76:155.
77. Kahanovitz N. Osteoporosis and fusion. Instr Course Lect 1992, 41:231-233.
78. Yablon I.G. The effect of methylmethacrylate on fracture healing. Clin Orthop Relat Res 1976, 114:358-363.
79. Goldring S.R., Schiller A.L., Roelke M., et al. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 1983, 65:575-584.
80. Whitehill R., Stowers S.F., Fechner R.E., et al. Posterior cervical fusions using cerclage wires, methylmethacrylate cement and autogenous bone graft. An experimental study of a canine model. Spine 1987, 12:12-22.
81. Whitehill R., Drucker S., McCoig J.A., et al. Induction and characterization of an interface tissue by implantation of methylmethacrylate cement into the posterior part of the cervical spine of the dog. J Bone Joint Surg Am 1988, 70:51-59.
82. Maloney W.J., Jasty M., Rosenberg A., et al. Bone lysis in well-fixed cemented femoral components. J Bone Joint Surg Br 1990, 72:966-970.
83. Eschenroeder H.C., Krackow K.A. Late onset femoral stress fracture associated with extruded cement following hip arthroplasty. A case report. Clin Orthop Relat Res 1988, 236:210-213.
84. Panchbhavi V.K., Vallurupalli S., Morris R., et al. The use of calcium sulfate and calcium phosphate composite graft to augment screw purchase in osteoporotic ankles. Foot Ankle Int 2008, 29:593-600.
85. Chapman M.W., Bucholz R., Cornell C. Treatment of acute fractures with a collagen-calcium phosphate graft material: a randomized clinical trial. J Bone Joint Surg Am 1997, 79:495-502.
86. Lee D.D., Tofighi A., Aiolova M., et al. α-BSM: a biomimetic bone substitute and drug delivery vehicle. Clin Orthop Relat Res 1999, 367(Suppl):S396-S405.
87. Blom E.J., Klein-Nulend J., Wolke J.G., et al. Transforming growth factor-β1 incorporation in calcium phosphate bone cement: material properties and release characteristics. J Biomed Mater Res 2002, 59:265-272.
88. Ruhe P.Q., Hedberg E.L., Padron N.T., et al. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am 2003, 85(Suppl 3):75-81.
89. Seeherman H., Li R., Bouxsein M., et al. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg Am 2006, 88:144-160.